XML 32 R22.htm IDEA: XBRL DOCUMENT v3.4.0.3
Segment Information
6 Months Ended
Mar. 31, 2016
Segment Reporting [Abstract]  
Segment Information
Segment Information
Operating segments are defined as components of an enterprise that engage in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker in deciding how to allocate resources and to assess performance. The Company's Chief Executive Officer is the Company's chief operating decision maker.
The Company reports its financial results for three operating and reportable segments: (i) Brooks Product Solutions, (ii) Brooks Global Services and (iii) Brooks Life Science Systems.
The Brooks Product Solutions segment provides a variety of products and solutions that enable improved throughput and yield in controlled operating environments. Those products include integrated systems that contain atmospheric and vacuum robots, as well as cryogenic pumps and cryochillers that provide vacuum pumping solutions.
The Brooks Global Services segment provides an extensive range of support services, including repair services, diagnostic support services, and installation services, which enable its customers to maximize process tool uptime and productivity. This segment also provides end-user customers with spare parts and productivity enhancement upgrades to maximize tool productivity.
The Brooks Life Science Systems segment provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and parts and support services to a wide range of life science customers including pharmaceutical companies, biotechnology companies, biobanks and research institutes. During the first quarter of fiscal year 2016, we completed an acquisition of BioStorage, a global provider of comprehensive outsource biological sample service solutions, including collection, transportation, processing, storage, protection, retrieval and disposal of biological samples. These solutions combined with the Company's existing offerings, particularly automation for sample storage and formatting, provide customers with fully integrated sample management cold chain solutions which will help them increase productivity, efficiencies and speed to market.
The Company evaluates the performance and future opportunities of its segments and allocates resources to them based on their revenue, operating income (loss) and returns on invested assets. Operating income (loss) for each segment includes selling, general and administrative expenses directly attributable to the segment. Amortization of acquired intangible assets (excluding completed technology), restructuring and other charges, pension settlement, in-process research and development, as well as other unallocated corporate expenses are excluded from the segments’ operating income (loss). The Company’s indirect overhead costs, which include various general and administrative expenses, are allocated among the segments based upon multiple cost drivers associated with the respective administrative function, including segment revenue, headcount, or benefits that each segment derives from a specific administrative function. Segment assets exclude cash, cash equivalents, marketable securities, deferred tax assets, assets held for sale and equity method investments.
The following is the summary of the financial information for the Company’s operating and reportable segments for the three and six months ended March 31, 2016 and 2015 (in thousands):
 
Brooks
Product
Solutions
 
Brooks
Global
Services
 
Brooks
Life Science
Systems
 
Total
Three Months Ended March 31, 2016:
 
 
 
 
 
 
 
Revenue
 
 
 
 
 
 
 
Product
$
86,790

 
$
3,448

 
$
11,224

 
$
101,462

Services

 
18,581

 
15,238

 
33,819

Total revenue
$
86,790

 
$
22,029

 
$
26,462

 
$
135,281

Gross profit
$
30,570

 
$
6,373

 
$
9,857

 
$
46,800

Segment operating income (loss)
$
4,791

 
$
1,867

 
$
(2,217
)
 
$
4,441

 
 
 
 
 
 
 
 
Three Months Ended March 31, 2015:
 
 
 
 
 
 
 
Revenue
 
 
 
 
 
 
 
Product
$
98,958

 
$
4,128

 
$
13,309

 
$
116,395

Services

 
18,709

 
4,209

 
22,918

Total revenue
$
98,958

 
$
22,837

 
$
17,518

 
$
139,313

Gross profit
$
33,995

 
$
7,043

 
$
4,987

 
$
46,025

Segment operating income (loss)
$
7,995

 
$
2,108

 
$
(4,391
)
 
$
5,712

 
 
 
 
 
 
 
 
Six Months Ended March 31, 2016:
 
 
 
 
 
 
 
Revenue
 
 
 
 
 
 
 
Product
$
163,351

 
$
6,066

 
$
21,225

 
$
190,642

Services

 
38,478

 
26,116

 
64,594

Total revenue
$
163,351

 
$
44,544

 
$
47,341

 
$
255,236

Gross profit
$
57,671

 
$
13,931

 
$
15,752

 
$
87,354

Segment operating income (loss)
$
5,128

 
$
4,470

 
$
(6,819
)
 
$
2,779

 
 
 
 
 
 
 
 
Six Months Ended March 31, 2015:
 
 
 
 
 
 
 
Revenue
 
 
 
 
 
 
 
Product
$
181,814

 
$
8,236

 
$
26,075

 
$
216,125

Services

 
37,798

 
8,126

 
45,924

Total revenue
$
181,814

 
$
46,034

 
$
34,201

 
$
262,049

Gross profit
$
60,917

 
$
15,506

 
$
8,690

 
$
85,113

Segment operating income (loss)
$
8,457

 
$
5,661

 
$
(9,907
)
 
$
4,211

 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
March 31, 2016
$
277,897

 
$
51,545

 
$
254,125

 
$
583,567

September 30, 2015
$
260,011

 
$
57,058

 
$
110,910

 
$
427,979

    
The following is a reconciliation of the Company’s operating and reportable segments' operating income (loss) and segment assets to the corresponding amounts presented in the accompanying unaudited Consolidated Balance Sheets and Consolidated Statements of Operations for the three and six months ended March 31, 2016 and 2015 (in thousands):
 
Three Months Ended
March 31,
 
Six Months Ended
March 31,
 
2016
 
2015
 
2016
 
2015
Segment operating income (loss)
$
4,441

 
$
5,712

 
$
2,779

 
$
4,211

Amortization of acquired intangible assets
3,091

 
1,914

 
5,302

 
3,826

Restructuring and other charges
7,336

 
685

 
8,811

 
3,353

Other unallocated corporate expenses
353

 
60

 
3,325

 
459

Total operating (loss) income
$
(6,339
)
 
$
3,053

 
$
(14,659
)
 
$
(3,427
)

 
March 31,
2016
 
September 30,
2015
Segment assets
$
583,567

 
$
427,979

Cash, cash equivalents and marketable securities
68,287

 
214,030

Deferred tax assets
4,575

 
89,959

Assets held for sale
2,895

 
2,900

Equity method investments
25,071

 
24,286

Other unallocated corporate net assets

 
500

Total assets
$
684,395

 
$
759,654